NO992944D0 - Virkestoffbµrer for avgivelse av apomorfin i munnhulen - Google Patents

Virkestoffbµrer for avgivelse av apomorfin i munnhulen

Info

Publication number
NO992944D0
NO992944D0 NO992944A NO992944A NO992944D0 NO 992944 D0 NO992944 D0 NO 992944D0 NO 992944 A NO992944 A NO 992944A NO 992944 A NO992944 A NO 992944A NO 992944 D0 NO992944 D0 NO 992944D0
Authority
NO
Norway
Prior art keywords
apomorphine
delivery
active ingredient
oral cavity
oral
Prior art date
Application number
NO992944A
Other languages
English (en)
Norwegian (no)
Other versions
NO992944L (no
Inventor
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO992944L publication Critical patent/NO992944L/no
Publication of NO992944D0 publication Critical patent/NO992944D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO992944A 1996-12-16 1999-06-16 Virkestoffbµrer for avgivelse av apomorfin i munnhulen NO992944D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19652268A DE19652268C2 (de) 1996-12-16 1996-12-16 Arzneizubereitung für die Freisetzung von Apomorphin in der Mundhöhle
PCT/EP1997/006529 WO1998026763A1 (fr) 1996-12-16 1997-11-21 Excipient pour liberer de l'apomorphine dans la cavite buccale

Publications (2)

Publication Number Publication Date
NO992944L NO992944L (no) 1999-06-16
NO992944D0 true NO992944D0 (no) 1999-06-16

Family

ID=7814859

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992944A NO992944D0 (no) 1996-12-16 1999-06-16 Virkestoffbµrer for avgivelse av apomorfin i munnhulen

Country Status (8)

Country Link
EP (1) EP0959875A1 (fr)
JP (1) JP2001506612A (fr)
KR (1) KR20000057627A (fr)
AU (1) AU746373B2 (fr)
CA (1) CA2274893A1 (fr)
DE (1) DE19652268C2 (fr)
NO (1) NO992944D0 (fr)
WO (1) WO1998026763A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US6291471B1 (en) 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males
PT1139793E (pt) 1998-12-23 2010-01-19 Sinai School Medicine Inibidores da resposta ao sabor amargo
US7314716B2 (en) 1999-11-19 2008-01-01 Mount Sinai School Of Medicine Gustducin γ subunit materials and methods
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
ES2331302T3 (es) 2001-05-01 2009-12-29 A.V. Topchiev Institute Of Petrochemical Synthesis Composiciones de hidrogel.
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
DE10252726B4 (de) * 2002-11-13 2008-05-08 Lts Lohmann Therapie-Systeme Ag Mehrschichtiges transmucosales therapeutisches System
AU2003277788A1 (en) * 2002-11-14 2004-06-03 Givaudan Sa Edible film containing food acid
KR100945741B1 (ko) * 2003-01-16 2010-03-05 부광약품 주식회사 염산아포모르핀을 함유하는 구강스프레이 제제
RU2380092C2 (ru) * 2004-01-30 2010-01-27 Кориум Интернэшнл, Инк. Быстро растворяющаяся пленка для доставки активного агента
US20050281757A1 (en) * 2004-06-17 2005-12-22 Sayed Ibrahim Oral care film
WO2010083035A2 (fr) 2009-01-14 2010-07-22 Corium International, Inc. Administration transdermique de tamsulosine
ES2699077T3 (es) * 2009-06-12 2019-02-07 Sunovion Pharmaceuticals Inc Apomorfina sublingual
PT2651357T (pt) * 2010-12-16 2020-06-17 Sunovion Pharmaceuticals Inc Películas sublinguais
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
KR20160108828A (ko) * 2013-11-11 2016-09-20 임팩스 라보라토리즈, 인코포레이티드 신속하게 붕괴되는 제형 및 사용 방법
EP4578461A3 (fr) 2015-04-21 2025-09-03 Sumitomo Pharma America, Inc. Méthodes de traitement de la maladie de parkinson par administration d'apomorphine à une muqueuse buccale
JP7603583B2 (ja) * 2018-10-18 2024-12-20 アビオール、インコーポレイテッド 慢性腎疾患随伴掻痒を処置する方法及びデバイス

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
DE2746414A1 (de) * 1977-10-15 1979-04-26 Gerlach Eduard Chem Fab Mittel zum dosieren von stoffen und verfahren zu seiner herstellung
WO1995028930A1 (fr) * 1994-04-22 1995-11-02 Pentech Pharmaceuticals, Inc. Formes galeniques et procede de traitement du dysfonctionnement de l'erection masculine
FR2732896B1 (fr) * 1995-04-11 1997-06-13 Prographarm Lab Forme pharmaceutique transdermique pour l'administration percutanee de l'apomorphine

Also Published As

Publication number Publication date
AU5654798A (en) 1998-07-15
JP2001506612A (ja) 2001-05-22
DE19652268A1 (de) 1998-06-18
EP0959875A1 (fr) 1999-12-01
WO1998026763A1 (fr) 1998-06-25
AU746373B2 (en) 2002-04-18
NO992944L (no) 1999-06-16
DE19652268C2 (de) 2000-06-29
KR20000057627A (ko) 2000-09-25
CA2274893A1 (fr) 1998-06-25

Similar Documents

Publication Publication Date Title
NO992944D0 (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
ID17553A (id) Bentuk-bentuk padatan dosis oral
DK1093815T3 (da) Oral 2-methyl-thieno-benzodiazepinformulering
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
TR199501137A2 (tr) Terapötik olarak aktif bilesenler
DK0797991T3 (da) Lægemiddelformulering med forhalet frigivelse
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
DE69530325D1 (de) Aerosol-arzneiformulierungen
MA26456A1 (fr) Formulations pharmaceutiques pour la distribution prolongee de medicament.
FI980822A7 (fi) Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
IS2004B (is) Lyfjasamsetningar sem innihalda vorikónasól
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
FI951316L (fi) Peroraalinen formulaatio
FI970934L (fi) Implantoitava valukappale vaikuttavien aineiden annostelemiseksi kasveihin
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
NO992564D0 (no) Anvendelsen av blandinger av aktive bestanddeler for fremstilling av hypokolesterinemiske midler
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
IT1291340B1 (it) Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale
HU9802886D0 (en) Substituted heterocyclic benzocycloalkenes and their use as analgetic active ingredients
NO975680L (no) Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application